Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Biora Therapeutics's peak revenue was $144.0M in 2019. The peak quarterly revenue was $542.0K in 2024(q1).
Biora Therapeutics's revenue increased from $144.0m in 2019 to $4.0K currently. That's a -100.0% change in annual revenue.
| Fiscal year / year | Biora Therapeutics revenue |
|---|---|
| 2019 | $144.0M |
| 2020 | $162,000 |
| 2021 | $1.2M |
| 2022 | $305,000 |
| 2023 | $4,000 |
How accurately did Biora Therapeutics' revenue projections match actual performance?
Biora Therapeutics saw the greatest revenue growth in 2021, when revenue increased by 669.75%.
Biora Therapeutics had the lowest revenue growth in 2020, when revenue changed by -99.89%.
| Year | Biora Therapeutics growth |
|---|---|
| 2020 | -100%↓ |
| 2021 | 670%↑ |
| 2022 | -76%↓ |
| 2023 | -99%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | $56,000 | $106,000 |
| 2021 | $167,000 | $463,000 | $32,000 | $359,000 |
| 2022 | $107,000 | $104,000 | $80,000 | $14,000 |
| 2023 | $2,000 | $2,000 | - | - |
| 2024 | $542,000 | $318,000 | $32,000 | - |
Do you work at Biora Therapeutics?
Did Biora Therapeutics meet its revenue projections?
| CEO | Harry Stylli Ph.d |
| Company Type | Public |
| Employees Number | 674 |
| Date Founded | 2010 |
| Headquarters | San Diego, California |
| Number of Locations | 6 |
| Revenue | $4,000 |
| Net Income | -$38,157,000 |
| Gross Proft | $43.5M (2019) |
| Tax Rate | 0.0% |
| Total Assets | $53,525,000 |
| Ticker | PROG |
Biora Therapeutics received early financing of $13.5M on 2013-06-27.
| Series | Round size | Date |
|---|---|---|
| Series A | $13.5M | 06/2013 |
| Series B | $125M | 11/2017 |
| Post Ipo Equity | $25M | 02/2021 |
| Post Ipo Equity | $40M | 06/2021 |
| Post Ipo Equity | $20M | 10/2021 |
| Investors | Security type |
|---|---|
| Athyrium Capital Management LP | Series B |
Biora Therapeutics's top competitor, AmeriPath Holdings Inc, earned an annual revenue of $1.4B.
Biora Therapeutics's smallest competitor is Standard Molecular with revenue of $330.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| OpGen | - | $3.4M | 48 | - |
| AmeriPath Holdings Inc | - | $1.4B | 3,979 | - |
| PierianDx | - | $15.8M | 221 | - |
| Standard Molecular | - | $330,000 | 7 | - |
| Medical Diagnostic Laboratories | - | $47.0M | 322 | - |
| Integra Seating | - | $13.5M | 18 | - |
| Univera | - | $51.4M | 99 | - |
| Spectera Inc | - | $1.1B | 10,001 | - |
| Global Medical Solutions | - | $17.7M | 10 | - |
| Burkhart Dental Supply | - | $470,000 | 50 | - |
Zippia gives an in-depth look into the details of Biora Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Biora Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Biora Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Biora Therapeutics. The data presented on this page does not represent the view of Biora Therapeutics and its employees or that of Zippia.
Biora Therapeutics may also be known as or be related to Biora Therapeutics, Biora Therapeutics Inc, PROGENITY, INC., Progenity and Progenity, Inc.